Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of treatment with cinacalcet and with cinacalcet plus
alendronate in controlling bone loss induced by primary hyperparathyroidism.